Day: December 11, 2023

Positive preliminary efficacy data with a favorable safety profile support plans to develop NX-5948 broadly in chronic lymphocytic leukemia (CLL) Rapid durable complete responses in a heavily pretreated relapsed/refractory patient population support continued development of NX-2127 in non-Hodgkin lymphoma (NHL) Nurix will webcast a Key Opinion Leader (KOL) event at 8:30 p.m. PT today to review data presented at the ASH meeting from its BTK degrader portfolio SAN FRANCISCO, Dec. 11, 2023 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with hematologic malignancies and solid tumors, today presented positive clinical data from its orally available degraders of BTK, NX-5948 and NX-2127, which are being evaluated...

Preliminary evidence of clinical antimyeloma activity, including reduction in paraprotein, demonstrated in multiple patients Clean safety profile with only Grade 1 and 2 treatment related adverse events and no dose limiting toxicities or dose reductions Clinical activity, safety profile, and dose-dependent increases in immune cell activation support potential for combination studies with other multiple myeloma agents, including BCMA- and CD38-directed therapies Company to pursue strategic partnership for combination studies, resulting in extension of cash runway into 2026 Company to host conference call and webcast today at 4:30 pm ET SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address...

Substantial, dose-dependent reductions in serum hepcidin and increases in serum iron Hematologic response demonstrated by increased hemoglobin levels and reduction in transfusion burden DISC-0974 was generally well-tolerated at all evaluated dosesWATERTOWN, Mass., Dec. 11, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced data from initial dose cohorts of its ongoing phase 1b/2 study of DISC-0974, a monoclonal antibody designed to suppress hepcidin by inhibiting the hemojuvelin (HJV) co-receptor, in MF patients with anemia. The initial data demonstrated that treatment with DISC-0974 substantially decreased serum hepcidin,...

TORONTO, Dec. 11, 2023 (GLOBE NEWSWIRE) — Shawcor Ltd., dba Mattr Infratech (“Mattr” or the “Company”) (TSX: MATR) announced today the publication of its updated Investor Presentation. Mattr will be hosting an Investor Day at 12:45pm ET in Toronto, where management will discuss the Company’s vision. A live webcast of the event will be available on its Investor Centre at https://investors.mattr.com. Participants will need to register in advance of the event to participate. A replay of the event will be available on the Company’s Investor Centre shortly after the day concludes. About MattrMattr is a growth-oriented, global materials technology company broadly serving critical infrastructure markets, including electrification, transportation, communication, water management and energy. Its two business segments, Composite Technologies...

All RUBY patients with ≥5 months follow-up have achieved a normal hemoglobin level and a fetal hemoglobin level of >40% All patients treated in the RUBY trial are free of vaso-occlusive events post-EDIT-301 infusion EDIT-301 was well-tolerated and demonstrated a safety profile consistent with myeloablative conditioning with busulfan and autologous hematopoietic stem cell transplant EDIT-301 is now known as renizgamglogene autogedtemcel (reni-cel) Company-sponsored webinar on the RUBY and EdiTHAL data today at 1:00 p.m. ET; ASH poster presentation today at 9:00 p.m. ET/6:00 p.m. PT CAMBRIDGE, Mass., Dec. 11, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced new safety and efficacy data in 17 patients treated with EDIT-301, now known as renizgamglogene autogedtemcel...

SRIVARU provides affordable premium electric two-wheeled vehicles that provide an exceptional riding experienceSRIVARU becomes the first India-based, U.S.-listed electric motorcycle companyFormer Tesla Executive, Mohanraj Ramasamy, assumes role as CEO of the combined companies Poised to capture a significant share of the multi-billion-dollar Indian and global EV markets based on surging demand, state-of-the-art technologies and capital-efficient business model Expected to commence trading on Nasdaq under new ticker symbol “SVMH” effective today, December 11, 2023 Delaware, USA and Coimbatore, India, Dec. 11, 2023 (GLOBE NEWSWIRE) — SRIVARU Holding Limited (Nasdaq: SVMH; SVMHW, MOBVU, MOBV, MOBVW) (“SRIVARU” or the “Company”), a commercial-stage provider of premium electric motorcycles, today provided a business update...

Turin, 11th December 2023. Iveco Group N.V. (EXM: IVG) announces that, under the ongoing initial tranche of the common share buyback program announced on 14th April 2023, the Company completed on a daily basis, starting from 4th December 2023 to 8th December 2023 the following transactions:Date Number of repurchased Common Shares Average net price (euro) Total net consideration (euro)4 December 2023 36,000 7.6118 274,025.345 December 2023 36,000 7.7060 277,414.386 December 2023 35,000 7.8616 275,157.067 December 2023 34,500 7.9324 273,666.398 December 2023 35,200 7.9369 279,378.57Total 176,700 7.8078 1,379,641.73An overall overview of the purchases carried out under the current share buyback program as well as the details of the above transactions, are available on the Company’s corporate website at the following...

Update share buyback program (11 December 2023) Regulated information 11 December 2023 – 17.45 CET On 22 September 2023, Kinepolis Group announced the launch of its Share buyback program to cover share options. This program started on 25 September 2023 and ends on 24 March 2024 at the latest. Under this program, Kinepolis Group may buy back, through the appointed independent intermediary, up to 151,000 shares on Euronext Brussels for a total maximum amount of € 8 million. During the period from 4 December 2023 to 8 December 2023, the following transactions were carried out on Euronext Brussels under this program:Date Number of shares Average price (EUR)1 Lowest price (EUR) Highest price(EUR) Total(EUR)4/12/2023 2,150 € 45.04 € 44.65 € 45.40 € 96,837.205/12/2023 952 € 44.64 € 44.30 € 44.80 € 42,501.906/12/2023 3,561 €...

The Extra General Meeting (the “EGM”) in Anoto Group AB (publ) (the “Company”) has been held on 11 December 2023 and in particular the following decisions were resolved. The Board The EGM decided that the Board of Directors for the period until the end of the next AGM shall consist of Dennis Song, Injoon Jeong, Pedro Pinto and Hans Haywood. The EGM elected Dennis Song as the Chairman of the Board of Directors. Remuneration for the Board of Directors The EGM resolved that the remuneration to the Board of Directors shall be paid in accordance with the resolution of the AGM (i.e. SEK 900,000 to the Chairman of the Board of Directors and SEK 300,000 to each of the other ordinary members of the Board of Directors who are not employed by the group to be reduced proportionally taking into account that the new Board of Directors will not serve...

Sherilyn Anderson Elected Vice Chair of First Fed BoardVice Chair Sherilyn Anderson, CEO Matt Deines, and Board Chair Cindy Finnie of First Northwest Bancorp (FNWB).PORT ANGELES, Wash., Dec. 11, 2023 (GLOBE NEWSWIRE) — First Fed Bank, subsidiary of First Northwest Bancorp (NASDAQ: FNWB) (“Company”), today announced that Sherilyn Anderson has been elected as to Board Vice Chair. Anderson has served as a Board Member since 2020.  “Sherilyn is a seasoned financial leader with deep banking industry experience. She brings a strong focus on financial stewardship while navigating investment and growth opportunities,” said Matt Deines, President and CEO of First Fed Bank and FNWB.  “As a community bank, First Fed plays a vital role in partnering with people and local businesses on their financial strategics. I’m excited...